Contract Pharma Manufacturing Solutions
-
Psychedelics: Drug Development Capabilities
10/30/2023
Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.
-
Fill Finish Capabilities: COVID-19
6/3/2020
Bringing Covid-19 therapeutic solutions to the clinic and market with speed, precision and scalability is now a challenge with unparalleled consequence. Ajinomoto Bio-Pharma Services remains committed to helping customers address the global demand for a solution.
-
Particle Control In Biopharmaceuticals
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
-
Integrated Vector Production Capabilities
10/29/2019
From products and services to complete manufacturing offerings, find out how MilliporeSigma can help you produce better, faster viral vectors.
-
Accelerating Product Development With Intelligent Collaboration
We have a global network ready to deliver end-to-end development and manufacturing expertise. Collaborating with you, we can help take your molecule all the way from early clinical phases through commercial manufacture and lifecycle management.
-
Customized CMC Solutions
Leverage customizable CMC solutions to address unique developmental challenges and propel your molecule toward IND filing and beyond, ensuring an efficient transition to the next stage of development.
-
Linking Antibody To Drug With ThioBridge® Conjugation Technology For Better ADCs
1/4/2024
Learn how an advanced conjugation technology can provide a more uniform DAR profile, enhanced linker stability, and improved pharmacokinetic properties, paving the way for more efficacious ADCs.
-
Antibody Drug Conjugates: Link Your Antibody To Its Fullest Potential
Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.
-
ADCs: From Design To Development
1/4/2024
Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.
-
Enviero Progesterone: Green-Chemistry Progesterone API
Enviero progesterone is the first compound launched from Pfizer CentreOne’s Enviero green-chemistry program and is being adopted across Pfizer to provide the latest in lower environmental impact products for patients around the world.